Home›Erythropoietic Agents

Erythropoietic Agents

1 interaction on record

Erythropoietic Agents + Lenalidomide⚠️Major

Concomitant use with lenalidomide may increase the risk of thrombosis. Should be used with caution after benefit-risk assessment.

Data sourced from U.S. FDA drug labeling via openFDA and the NIH National Library of Medicine, supplemented with a small number of well-established interactions from curated clinical references. For informational purposes only. Always consult your pharmacist or physician.